196 related articles for article (PubMed ID: 8680883)
1. Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.
Wang Z; Morris GF; Rice AP; Xiong W; Morris CB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):128-38. PubMed ID: 8680883
[TBL] [Abstract][Full Text] [Related]
2. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
Veschambre P; Simard P; Jalinot P
J Mol Biol; 1995 Jul; 250(2):169-80. PubMed ID: 7608968
[TBL] [Abstract][Full Text] [Related]
3. Direct interaction of human TFIID with the HIV-1 transactivator tat.
Kashanchi F; Piras G; Radonovich MF; Duvall JF; Fattaey A; Chiang CM; Roeder RG; Brady JN
Nature; 1994 Jan; 367(6460):295-9. PubMed ID: 8121496
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
Majello B; Napolitano G; Lania L
AIDS; 1998 Oct; 12(15):1957-64. PubMed ID: 9814863
[TBL] [Abstract][Full Text] [Related]
5. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.
Suñé C; García-Blanco MA
J Virol; 1995 May; 69(5):3098-107. PubMed ID: 7707538
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex.
Kashanchi F; Khleif SN; Duvall JF; Sadaie MR; Radonovich MF; Cho M; Martin MA; Chen SY; Weinmann R; Brady JN
J Virol; 1996 Aug; 70(8):5503-10. PubMed ID: 8764062
[TBL] [Abstract][Full Text] [Related]
8. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.
Liu X; Miller CW; Koeffler PH; Berk AJ
Mol Cell Biol; 1993 Jun; 13(6):3291-300. PubMed ID: 8497252
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB.
Veschambre P; Roisin A; Jalinot P
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2235-45. PubMed ID: 9292011
[TBL] [Abstract][Full Text] [Related]
10. Tat gets the "green" light on transcription initiation.
Brady J; Kashanchi F
Retrovirology; 2005 Nov; 2():69. PubMed ID: 16280076
[TBL] [Abstract][Full Text] [Related]
11. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
[TBL] [Abstract][Full Text] [Related]
12. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP.
Yu L; Loewenstein PM; Zhang Z; Green M
J Virol; 1995 May; 69(5):3017-23. PubMed ID: 7707528
[TBL] [Abstract][Full Text] [Related]
13. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment.
Xiao H; Lis JT; Jeang KT
Mol Cell Biol; 1997 Dec; 17(12):6898-905. PubMed ID: 9372921
[TBL] [Abstract][Full Text] [Related]
14. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function.
Ou SH; Garcia-Martínez LF; Paulssen EJ; Gaynor RB
J Virol; 1994 Nov; 68(11):7188-99. PubMed ID: 7933101
[TBL] [Abstract][Full Text] [Related]
15. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes.
Ohana B; Moore PA; Ruben SM; Southgate CD; Green MR; Rosen CA
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):138-42. PubMed ID: 8419915
[TBL] [Abstract][Full Text] [Related]
16. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
Deng L; de la Fuente C; Fu P; Wang L; Donnelly R; Wade JD; Lambert P; Li H; Lee CG; Kashanchi F
Virology; 2000 Nov; 277(2):278-95. PubMed ID: 11080476
[TBL] [Abstract][Full Text] [Related]
17. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.
Kamine J; Subramanian T; Chinnadurai G
J Virol; 1993 Nov; 67(11):6828-34. PubMed ID: 8411386
[TBL] [Abstract][Full Text] [Related]
18. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme.
Cujec TP; Cho H; Maldonado E; Meyer J; Reinberg D; Peterlin BM
Mol Cell Biol; 1997 Apr; 17(4):1817-23. PubMed ID: 9121429
[TBL] [Abstract][Full Text] [Related]
19. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein.
Mahanta SK; Scholl T; Yang FC; Strominger JL
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6324-9. PubMed ID: 9177216
[TBL] [Abstract][Full Text] [Related]
20. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
Rhim H; Rice AP
Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
